4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000126
Director sold 3,000 shares at $36.00 ($108,000)
- Director acquired 3,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pande Atul Director | 2026-11-11 | Option exercise 10b5-1 | +3,000 | $8.43 | $25,290 | 119,731 | D |
| Pande Atul Director | 2026-11-11 | Sale 10b5-1 | −3,000 | $36.00 | $108,000 | 116,731 | D |
| Derivatives | |||||||
| Pande Atul Director | 2026-11-11 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,000 | 62,181 | D | ||
| Open-market sales · 3,000 sh · avg $36.00 · $108,000 | |||||||
Loading xslF345X06/wk-form4_1794519707.xml…